PIRAMAL PHARMA SOLUTIONS SUPPORTS THERACOSBIO WITH INTEGRATED DRUG SUBSTANCE/DRUG PRODUCT PROGRAM FOR BEXAGLIFLOZIN ...Middle East

News by : (PR Newswire) -
TheracosBio recently received FDA approval for Brenzavvy™ (bexagliflozin), an oral sodium-glucose cotransporter 2 (SGLT2) inhibitor Piramal supported TheracosBio with starting materials, active pharmaceutical ingredient (API), and oral solid dosage formulation Integrated drug development...

Read More Details
Finally We wish PressBee provided you with enough information of ( PIRAMAL PHARMA SOLUTIONS SUPPORTS THERACOSBIO WITH INTEGRATED DRUG SUBSTANCE/DRUG PRODUCT PROGRAM FOR BEXAGLIFLOZIN )

Also on site :

Most Viewed News
جديد الاخبار